Specify a stock or a cryptocurrency in the search bar to get a summary
China Grand Pharmaceutical and Healthcare Holdings Ltd
0512Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers respiratory, ophthalmology, cerebro-cardiovascular emergency, and biotechnology related products. It manufactures and sells pharmaceutical, taurine, agrochemicals, chemical medicine, and amino acid series products. In addition, the company provides bio-pesticides and additives; disposal surgical products; and Chinese medicine and health food products, as well as engages in the treatment of sewage. Grand Pharmaceutical Group Limited has a strategic cooperation agreement with the Eye Hospital of Wenzhou Medical University in the field of ophthalmic drug research and development. It operates in the People's Republic of China, the rest of Asia, the United States, Europe, and internationally. The company was formerly known as China Grand Pharmaceutical and Healthcare Holdings Limited. The company was incorporated in 1995 and is based in Central, Hong Kong. Address: The Center, Central, Hong Kong
Analytics
WallStreet Target Price
45.16 HKDP/E ratio
6.7681Dividend Yield
5.51 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 0512
Dividend Analytics 0512
Dividend growth over 5 years
–Continuous growth
1 yearPayout Ratio 5 years average
21 %Dividend History 0512
Stock Valuation 0512
Financials 0512
Results | 2019 | Dynamics |